- Home
- GDL vs NTRB Comparison
GDL vs NTRB Comparison
Compare GDL & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDL
- NTRB
- Stock Information
- Founded
- GDL 2006
- NTRB 2016
- Country
- GDL United States
- NTRB United States
- Employees
- GDL N/A
- NTRB N/A
- Industry
- GDL Investment Managers
- NTRB Industrial Specialties
- Sector
- GDL Finance
- NTRB Health Care
- Exchange
- GDL Nasdaq
- NTRB Nasdaq
- Market Cap
- GDL 93.3M
- NTRB 82.3M
- IPO Year
- GDL N/A
- NTRB N/A
- Fundamental
- Price
- GDL $8.45
- NTRB $6.44
- Analyst Decision
- GDL
- NTRB Buy
- Analyst Count
- GDL 0
- NTRB 1
- Target Price
- GDL N/A
- NTRB $13.00
- AVG Volume (30 Days)
- GDL 11.2K
- NTRB 192.4K
- Earning Date
- GDL 01-01-0001
- NTRB 09-05-2025
- Dividend Yield
- GDL 6.02%
- NTRB N/A
- EPS Growth
- GDL N/A
- NTRB N/A
- EPS
- GDL N/A
- NTRB N/A
- Revenue
- GDL N/A
- NTRB $2,398,437.00
- Revenue This Year
- GDL N/A
- NTRB $560.75
- Revenue Next Year
- GDL N/A
- NTRB $588.39
- P/E Ratio
- GDL N/A
- NTRB N/A
- Revenue Growth
- GDL N/A
- NTRB 18.92
- 52 Week Low
- GDL $7.65
- NTRB $2.98
- 52 Week High
- GDL $8.13
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- GDL 58.71
- NTRB 39.08
- Support Level
- GDL $8.35
- NTRB $6.05
- Resistance Level
- GDL $8.50
- NTRB $6.67
- Average True Range (ATR)
- GDL 0.06
- NTRB 0.44
- MACD
- GDL 0.01
- NTRB -0.04
- Stochastic Oscillator
- GDL 78.85
- NTRB 22.54
About GDL GDL Fund The of Beneficial Interest
GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.